Cancer Research Cancer Research Funding Available  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 3954-3960, September 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hyder, S. M.
Right arrow Articles by Makela, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyder, S. M.
Right arrow Articles by Makela, S.

Uterine Expression of Vascular Endothelial Growth Factor Is Increased by Estradiol and Tamoxifen1

Salman M. Hyder2, George M. Stancel, Constance Chiappetta, Lata Murthy, Holly L. Boettger-Tong and Sari Makela

Departments of Pharmacology [S. M. H., G. M. S., C. C., L. M., H. L. B-T., S. M.], Obstetrics, Gynecology, and Reproductive Sciences [S. M. H.], University of Texas Medical School, Houston, Texas 77225 and Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030 [L. M.]

Vascular endothelial growth factor (VEGF) is an endothelial-specific mitogen with potent angiogenic activity. Because vascular growth accompanies normal endometrial regeneration and may also be involved in uterine tumor growth, we studied VEGF regulation by 17ß-estradiol (E2) and tamoxifen, two agents that can increase uterine cell proliferation and tumor incidence. In immature, ovariectomized rats, E2 elevates uterine VEGF mRNA transiently, with a peak induction of 15–20-fold within 1 h. A maximum response is produced at a dose of 4 µg/kg E2, and induction is specific for estrogenic steroids. E2-dependent VEGF induction is inhibited by actinomycin D but not puromycin, suggesting that the effect is due at least in part to direct estrogen receptor regulation of VEGF transcription. PCR amplification and DNA sequencing indicated that VEGF188, VEGF164, and VEGF120 are all induced by E2, but the latter two are the predominant forms in the uterus. In situ hybridization shows a predominantly stromal expression of VEGF mRNA. The antiestrogens tamoxifen, 4-OH tamoxifen, and nafoxidine produce similar increases in uterine VEGF mRNA levels within 6 h, with 1 mg/kg tamoxifen producing a maximum response of 15–20-fold. The tamoxifen response was also inhibited by actinomycin D but not by puromycin, again suggesting direct transcriptional regulation of VEGF expression by antiestrogens. These findings raise the possibility that estrogen and antiestrogen effects on uterine edema, proliferation, and tumor incidence may involve local increases in tissue VEGF production.

1 This research was supported by a Grant-in-Aid from the American Heart Association, Texas Affiliate, and by NIH Grants HD-08615 and ES-06995.

2 To whom requests for reprints should be addressed, at Department of Pharmacology, University of Texas Medical School, 6431 Fannin, P.O. Box 20708, Houston, TX 77225.

Received 3/25/96. Accepted 7/ 2/96.




This article has been cited by other articles:


Home page
EndocrinologyHome page
K. H. Molitoris, A. A. Kazi, and R. D. Koos
Inhibition of Oxygen-Induced Hypoxia-Inducible Factor-1{alpha} Degradation Unmasks Estradiol Induction of Vascular Endothelial Growth Factor Expression in ECC-1 Cancer Cells in Vitro
Endocrinology, December 1, 2009; 150(12): 5405 - 5414.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S. M Hyder, Y. Liang, J. Wu, and V. Welbern
Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells
Endocr. Relat. Cancer, September 1, 2009; 16(3): 809 - 817.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. A. Kazi, K. H. Molitoris, and R. D. Koos
Estrogen Rapidly Activates the PI3K/AKT Pathway and Hypoxia-Inducible Factor 1 and Induces Vascular Endothelial Growth Factor A Expression in Luminal Epithelial Cells of the Rat Uterus
Biol Reprod, August 1, 2009; 81(2): 378 - 387.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. E. Toutain, L. Brouchet, I. Raymond-Letron, P. Vicendo, H. Berges, J. Favre, M.-J. Fouque, A. Krust, A.-M. Schmitt, P. Chambon, et al.
Prevention of Skin Flap Necrosis by Estradiol Involves Reperfusion of a Protected Vascular Network
Circ. Res., January 30, 2009; 104(2): 245 - 254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G.-S. Hwang, S.-W. Wang, W.-M. Tseng, C.-H. Yu, and P. S. Wang
Effect of hypoxia on the release of vascular endothelial growth factor and testosterone in mouse TM3 Leydig cells
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1763 - E1769.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
V L Bosquiazzo, J G Ramos, J Varayoud, M Munoz-de-Toro, and E H Luque
Mast cell degranulation in rat uterine cervix during pregnancy correlates with expression of vascular endothelial growth factor mRNA and angiogenesis
Reproduction, May 1, 2007; 133(5): 1045 - 1055.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. A. Kazi and R. D. Koos
Estrogen-Induced Activation of Hypoxia-Inducible Factor-1{alpha}, Vascular Endothelial Growth Factor Expression, and Edema in the Uterus Are Mediated by the Phosphatidylinositol 3-Kinase/Akt Pathway
Endocrinology, May 1, 2007; 148(5): 2363 - 2374.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S M Hyder
Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 667 - 687.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. J. Higgins, S. Liu, M. Abdelrahim, K. Yoon, K. Vanderlaag, W. Porter, R. P. Metz, and S. Safe
Vascular Endothelial Growth Factor Receptor-2 Expression Is Induced by 17{beta}-Estradiol in ZR-75 Breast Cancer Cells by Estrogen Receptor {alpha}/Sp Proteins
Endocrinology, July 1, 2006; 147(7): 3285 - 3295.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. A. Kazi, J. M. Jones, and R. D. Koos
Chromatin Immunoprecipitation Analysis of Gene Expression in the Rat Uterus in Vivo: Estrogen-Induced Recruitment of Both Estrogen Receptor {alpha} and Hypoxia-Inducible Factor 1 to the Vascular Endothelial Growth Factor Promoter
Mol. Endocrinol., August 1, 2005; 19(8): 2006 - 2019.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Bhanoori, K. Arvind Babu, N.G. Pavankumar Reddy, K. Lakshmi Rao, K. Zondervan, M. Deenadayal, S. Kennedy, and S. Shivaji
The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study
Hum. Reprod., July 1, 2005; 20(7): 1844 - 1849.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
H. Zhang, T. McElrath, W. Tong, and J. W Pollard
The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation
J. Endocrinol., January 1, 2005; 184(1): 129 - 140.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van Oosterom, and E. A. De Bruijn
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacol. Rev., December 1, 2004; 56(4): 549 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. D. Albrecht, V. A. Robb, and G. J. Pepe
Regulation of Placental Vascular Endothelial Growth/Permeability Factor Expression and Angiogenesis by Estrogen during Early Baboon Pregnancy
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5803 - 5809.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. T.V. Le and D. R. Richardson
Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation
Blood, November 1, 2004; 104(9): 2967 - 2975.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Tangkeangsirisin and G. Serrero
PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells
Carcinogenesis, September 1, 2004; 25(9): 1587 - 1592.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. A. Vonnahme and S. P. Ford
Differential Expression of the Vascular Endothelial Growth Factor-Receptor System in the Gravid Uterus of Yorkshire and Meishan Pigs
Biol Reprod, July 1, 2004; 71(1): 163 - 169.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wu, J. Richer, K. B. Horwitz, and S. M. Hyder
Progestin-Dependent Induction of Vascular Endothelial Growth Factor in Human Breast Cancer Cells: Preferential Regulation by Progesterone Receptor B
Cancer Res., March 15, 2004; 64(6): 2238 - 2244.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Abdel-Majid and J. S. Marshall
Prostaglandin E2 Induces Degranulation-Independent Production of Vascular Endothelial Growth Factor by Human Mast Cells
J. Immunol., January 15, 2004; 172(2): 1227 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. G. Lamping, L. P. Christensen, and R. J. Tomanek
Estrogen therapy induces collateral and microvascular remodeling
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2039 - H2044.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. J. Mabjeesh, M. T. Willard, C. E. Frederickson, H. Zhong, and J. W. Simons
Androgens Stimulate Hypoxia-inducible Factor 1 Activation via Autocrine Loop of Tyrosine Kinase Receptor/Phosphatidylinositol 3'-Kinase/Protein Kinase B in Prostate Cancer Cells
Clin. Cancer Res., July 1, 2003; 9(7): 2416 - 2425.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. J. K. Anand, H.-J. Paust, K. Altenpohl, and A. K. Mukhopadhyay
Regulation of Vascular Endothelial Growth Factor Production by Leydig Cells In Vitro: The Role of Protein Kinase A and Mitogen-Activated Protein Kinase Cascade
Biol Reprod, May 1, 2003; 68(5): 1663 - 1673.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Stevens, J. Soden, P. E. Brenchley, S. Ralph, and D. W. Ray
Haplotype Analysis of the Polymorphic Human Vascular Endothelial Growth Factor Gene Promoter
Cancer Res., February 15, 2003; 63(4): 812 - 816.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. B. Pillai, J. M. Jones, and R. D. Koos
Treatment of Rats with 17{beta}-Estradiol or Relaxin Rapidly Inhibits Uterine Estrogen Receptor {beta}1 and {beta}2 Messenger Ribonucleic Acid Levels
Biol Reprod, December 1, 2002; 67(6): 1919 - 1926.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Buteau-Lozano, M. Ancelin, B. Lardeux, J. Milanini, and M. Perrot-Applanat
Transcriptional Regulation of Vascular Endothelial Growth Factor by Estradiol and Tamoxifen in Breast Cancer Cells: A Complex Interplay between Estrogen Receptors {alpha} and {beta}
Cancer Res., September 1, 2002; 62(17): 4977 - 4984.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. M. Hyder
The Role of Steroid Hormones on the Regulation of Vascular Endothelial Growth Factorm
Am. J. Pathol., July 1, 2002; 161(1): 345 - 346.
[Full Text] [PDF]


Home page
IOVSHome page
N. Miyamoto, M. Mandai, H. Takagi, I. Suzuma, K. Suzuma, S. Koyama, A. Otani, H. Oh, and Y. Honda
Contrasting Effect of Estrogen on VEGF Induction under Different Oxygen Status and Its Role in Murine ROP
Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 2007 - 2014.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ancelin, H. Buteau-Lozano, G. Meduri, M. Osborne-Pellegrin, S. Sordello, J. Plouet, and M. Perrot-Applanat
A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus
PNAS, April 30, 2002; 99(9): 6023 - 6028.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. R. Nayak and R. M. Brenner
Vascular Proliferation and Vascular Endothelial Growth Factor Expression in the Rhesus Macaque Endometrium
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1845 - 1855.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Chandrasekar, S. Nattel, and J.-F. Tanguay
Coronary artery endothelial protection after local delivery of 17{beta}-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1570 - 1576.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. A. Hildebrandt, J. S. Babischkin, R. D. Koos, G. J. Pepe, and E. D. Albrecht
Developmental Regulation of Vascular Endothelial Growth/Permeability Factor Messenger Ribonucleic Acid Levels in and Vascularization of the Villous Placenta During Baboon Pregnancy
Endocrinology, May 1, 2001; 142(5): 2050 - 2057.
[Abstract] [Full Text]


Home page
Exp. Biol. Med.Home page
X. Long, K. A. Burke, R. M. Bigsby, and K. P. Nephew
Effects of the Xenoestrogen Bisphenol A on Expression of Vascular Endothelial Growth Factor (VEGF) in the Rat
Experimental Biology and Medicine, May 1, 2001; 226(5): 477 - 482.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Krumenacker, S. M. Hyder, and F. Murad
Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus
PNAS, January 16, 2001; 98(2): 717 - 722.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. H. Ali, A. L. O’Donnell, D. Balu, M. B. Pohl, M. J. Seyler, S. Mohamed, S. Mousa, and P. Dandona
Estrogen Receptor-{{alpha}} in the Inhibition of Cancer Growth and Angiogenesis
Cancer Res., December 1, 2000; 60(24): 7094 - 7098.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Bausero, M.-H. Ben-Mahdi, J.-P. Mazucatelli, C. Bloy, and M. Perrot-Applanat
Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2033 - H2042.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. L. Blackwell, Z. A. Haroon, S. Shan, W. Saito, G. Broadwater, C. S. Greenberg, and M. W. Dewhirst
Tamoxifen Inhibits Angiogenesis in Estrogen Receptor-negative Animal Models
Clin. Cancer Res., November 1, 2000; 6(11): 4359 - 4364.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
A. Malamitsi-Puchner, J. Tziotis, A. Tsonou, E. Protonotariou, A. Sarandakou, and G. Creatsas
Changes in Serum Levels of Vascular Endothelial Growth Factor in Males and Females Throughout Life
Reproductive Sciences, September 1, 2000; 7(5): 309 - 312.
[Abstract] [PDF]


Home page
Cancer Res.Home page
J. Adams, P. J. Carder, S. Downey, M. A. Forbes, K. MacLennan, V. Allgar, S. Kaufman, S. Hallam, R. Bicknell, J. J. Walker, et al.
Vascular Endothelial Growth Factor (VEGF) in Breast Cancer: Comparison of Plasma, Serum, and Tissue VEGF and Microvessel Density and Effects of Tamoxifen
Cancer Res., June 1, 2000; 60(11): 2898 - 2905.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Hyder, Z. Nawaz, C. Chiappetta, and G. M. Stancel
Identification of Functional Estrogen Response Elements in the Gene Coding for the Potent Angiogenic Factor Vascular Endothelial Growth Factor
Cancer Res., June 1, 2000; 60(12): 3183 - 3190.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Sharkey, K. Day, A. McPherson, S. Malik, D. Licence, S. K. Smith, and D. S. Charnock-Jones
Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 402 - 409.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
A. M. Macpherson, D. F. Archer, S. Leslie, D.S. Charnock-Jones, W.K. Makkink, and S. K. Smith
The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium
Hum. Reprod., December 1, 1999; 14(12): 3080 - 3087.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
I. Suzuma, M. Mandai, H. Takagi, K. Suzuma, A. Otani, H. Oh, K. Kobayashi, and Y. Honda
17 {beta}-Estradiol Increases VEGF Receptor-2 and Promotes DNA Synthesis in Retinal Microvascular Endothelial Cells
Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 2122 - 2129.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Hyder, C. Chiappetta, and G. M. Stancel
Synthetic Estrogen 17alpha -Ethinyl Estradiol Induces Pattern of Uterine Gene Expression Similar to Endogenous Estrogen 17beta -Estradiol
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 740 - 747.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S. M. Hyder and G. M. Stancel
Regulation of Angiogenic Growth Factors in the Female Reproductive Tract by Estrogens and Progestins
Mol. Endocrinol., June 1, 1999; 13(6): 806 - 811.
[Full Text]


Home page
EndocrinologyHome page
J. W. Pollard
Editorial: Genetic Regulation of Estrogen Responsiveness
Endocrinology, February 1, 1999; 140(2): 553 - 555.
[Full Text]


Home page
Cancer Res.Home page
Z. Nawaz, G. M. Stancel, and S. M. Hyder
The Pure Antiestrogen ICI 182,780 Inhibits Progestin-induced Transcription
Cancer Res., January 1, 1999; 59(2): 372 - 376.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. C. Levine, X.-H. Liu, P. D. Greenberg, M. Eliashvili, J. D. Schiff, S. A. Aaronson, J. F. Holland, and A. Kirschenbaum
Androgens Induce the Expression of Vascular Endothelial Growth Factor in Human Fetal Prostatic Fibroblasts
Endocrinology, November 1, 1998; 139(11): 4672 - 4678.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
C. Y. Cheung
Vascular Endothelial Growth Factor: Possible Role in Fetal Development and Placental Function
Reproductive Sciences, July 1, 1997; 4(4): 169 - 177.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. Stoner, F. Wang, M. Wormke, T. Nguyen, I. Samudio, C. Vyhlidal, D. Marme, G. Finkenzeller, and S. Safe
Inhibition of Vascular Endothelial Growth Factor Expression in HEC1A Endometrial Cancer Cells through Interactions of Estrogen Receptor alpha and Sp3 Proteins
J. Biol. Chem., July 21, 2000; 275(30): 22769 - 22779.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ancelin, H. Buteau-Lozano, G. Meduri, M. Osborne-Pellegrin, S. Sordello, J. Plouet, and M. Perrot-Applanat
A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus
PNAS, April 30, 2002; 99(9): 6023 - 6028.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.